Respiratory Syncytial Virus (RSV)

Respiratory·MeSH: Communicable Diseases

32 drugs in development·10 companies·4 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
enflonsia	Merck & Co., Inc. (MRK)

Phase 3(1)

Drug	Company
palivizumab	ASTRAZENECA PLC (AZN)

Phase 2(2)

Drug	Company
EDP-938	ENANTA PHARMACEUTICALS INC (ENTA)
ivx-121	Icosavax, Inc. (ICVX)

Phase 1(24)

Drug	Company
h5 flu imp 10	Sanofi (SNY)
h5 flu imp 10	Sanofi (SNYNF)
h5 flu imp 11	Sanofi (SNYNF)
h5 flu imp 11	Sanofi (SNY)
h5 flu imp 12	Sanofi (SNY)
h5 flu imp 12	Sanofi (SNYNF)
h5 flu imp 2	Sanofi (SNYNF)
h5 flu imp 2	Sanofi (SNY)
h5 flu imp 3	Sanofi (SNY)
h5 flu imp 3	Sanofi (SNYNF)
h5 flu imp 7	Sanofi (SNYNF)
h5 flu imp 7	Sanofi (SNY)
h5 flu imp 8	Sanofi (SNY)
h5 flu imp 8	Sanofi (SNYNF)
h5 flu imp 9	Sanofi (SNYNF)
h5 flu imp 9	Sanofi (SNY)
h5 flu investigational medical product 1	Sanofi (SNY)
h5 flu investigational medical product 1	Sanofi (SNYNF)
rsv imp 4	Sanofi (SNYNF)
rsv imp 4	Sanofi (SNY)
rsv imp 5	Sanofi (SNY)
rsv imp 5	Sanofi (SNYNF)
rsv imp 6	Sanofi (SNYNF)
rsv imp 6	Sanofi (SNY)

Preclinical(3)

Drug	Company
AR-201	Aridis Pharmaceuticals, Inc. (ARDS)
gv2311	GENVEC INC (GNVC)
rsv vaccine	MYMETICS CORP (MYMX)

Unknown(1)

Drug	Company
Alinity® m and m2000™	ABBOTT LABORATORIES (ABT)

BioSniper tracks 32 drugs in development for Respiratory Syncytial Virus (RSV) across 10 companies.

There are 4 clinical trials targeting Respiratory Syncytial Virus (RSV) tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.